Predictive marker for response to trifluridine/tipiracil plus bevacizumab in metastatic colorectal cancer patients.
Takahashi T, Shigeyasu K, Kondo Y, Takeda S, Umeda H, Moriwake K, Kayano M, Sakurai Y, Nakamura S, Takahashi M, Nitta K, Yoshida K, Matsumi Y, Michiue H, Yamamoto H, Kishimoto H, Teraishi F, Shoji R, Kanaya N, Kashima H, Kakiuchi Y, Kuroda S, Kagawa S, Fujiwara T.
Takahashi T, et al.
BMC Cancer. 2025 Jan 2;25(1):1. doi: 10.1186/s12885-024-13370-8.
BMC Cancer. 2025.
PMID: 39748254
Free PMC article.